Oncotarget

Methodological Reports:

Mantle cell lymphoma-like lymphomas in c-myc-3’RR/p53+/- mice and c-myc-3’RR/Cdk4R24C mice: differential oncogenic mechanisms but similar cellular origin

Pauline Rouaud, Rémi Fiancette, Christelle Vincent-Fabert, Virginie Magnone, Michel Cogné, Pierre Dubus and Yves Denizot _

PDF  |  HTML  |  How to cite  |  Order a Reprint

Oncotarget. 2012; 3:586-593. https://doi.org/10.18632/oncotarget.474

Metrics: PDF 1404 views  |   HTML 1680 views  |   ?  


Abstract

Pauline Rouaud1, Rémi Fiancette1, Christelle Vincent-Fabert1, Virginie Magnone2, Michel Cogné1, Pierre Dubus3 and Yves Denizot1

1 UMR CNRS 7276, Faculté de Médecine, Limoges, France

2 CNRS and University of Nice Sophia Antipolis, Institut de Pharmacologie Moléculaire et Cellulaire, UMR 6097, Sophia Antipolis, France

3 EA2406, Université de Bordeaux, Bordeaux, France

Received: April 3, 2012; Accepted: April 28, 2012; Published: May 9, 2012;

Keywords: Mantle cell lymphoma, c-myc

Correspondence:

Yves Denizot, email:

Abstract

Mantle cell lymphoma (MCL) is a malignant lymphoproliferative B-cell disorder that does not occur spontaneously in mice but experimental mice model have been developed. Recently two different mice models prone to develop MCL-like lymphomas were generated: c-myc-3’RR/Cdk4R24C mice and c-myc-3’RR/p53+/- mice. Comparison of their gene expression profiles does not highlight specific differences other than those in relation with their specific mutational status (i.e., Cdk4R24C mutation or p53 mutation). We propose that similarly to typical human MCL and its blastoid or cyclin-D1 variants that correspond to the same genetic entity, MCL-like lymphomas of c-myc-3’RR/p53+/- mice and c-myc-3’RR/Cdk4R24C mice represent a spectrum of the same entity.


Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.
PII: 474